- Clover Health Investments (CLOV) +37%.
- Aytu Biopharma (AYTU) +20%.
- NextDecade Corporation (NEXT) +20% after Morgan Stanley upgrades on Rio Grande LNG outlook.
- Cyclerion Therapeutics (CYCN) +16%.
- The Wendy's (WEN) +16%.
- Stitch Fix (SFIX) +14% on Q3 results.
- PDS Biotechnology (PDSB) +13% after PDS0101 combo shows tumor regression in HPV+ cancer patients.
- Dada Nexus Limited (DADA) +11% on Q1 results.
- India Globalization Capital (IGC) +11% after completing Cohort 2 of its Phase 1 clinical trial.
- Safe-T Group Ltd (SFET) +10%.
- SemiLEDs Corporation (LEDS) +10%.
- MoSys, Inc. (MOSY) +9%.
- Contango Oil & Gas Company (MCF) +9% after agreeing to merge with KKR's Independence Energy in an all-stock deal.
- Tuscan Holdings Corp. (THCB) +9% after announcing record date for business combination.
- Bionano Genomics, Inc. (BNGO) +8%.
- American Resources Corporation (AREC) +8%.
- CarLotz (LOTZ) +8%.
- AgEagle Aerial Systems (UAVS) +8%.
- Vinco Ventures (BBIG) +7%.
- Chico's FAS (CHS) +7% on Q1 results.
- Entera Bio Ltd. (ENTX) +7%.
- CPS Technologies Corporation (CPSH) +7%.
- VBI Vaccines (VBIV) +7% after FDA grants VBI-1901 'fast track' status.
- Workhorse Group Inc. (WKHS) +6%.
- Carver Bancorp, Inc. (CARV) +6%.